Considerations regarding noncredible performance in the neuropsychological assessment of patients with multiple sclerosis: A case series.

Clinical assessment malingering multiple sclerosis neuropsychology performance validity

Journal

Applied neuropsychology. Adult
ISSN: 2327-9109
Titre abrégé: Appl Neuropsychol Adult
Pays: United States
ID NLM: 101584082

Informations de publication

Date de publication:
Historique:
medline: 25 4 2023
pubmed: 14 9 2021
entrez: 13 9 2021
Statut: ppublish

Résumé

Determining the validity of data during clinical neuropsychological assessment is crucial for proper interpretation, and extensive literature has emphasized myriad methods of doing so in diverse samples. However, little research has considered noncredible presentation in persons with multiple sclerosis (pwMS). PwMS often experience one or more factors known to impact validity of data, including major neurocognitive impairment, psychological distress/psychogenic interference, and secondary gain. This case series aimed to illustrate the potential relationships between these factors and performance validity testing in pwMS. Six cases from an IRB-approved database containing pwMS referred for neuropsychological assessment at a large, academic medical center involving at least one of the above-stated factors were identified. Backgrounds, neuropsychological test data, and clinical considerations for each were reviewed. Interestingly, no pwMS diagnosed with major neurocognitive impairment was found to have noncredible performance, nor was any patient with noncredible performance in the absence of notable psychological distress. Given the variability of noncredible performance and multiplicity of factors affecting performance validity in pwMS, clinicians are strongly encouraged to consider psychometrically appropriate methods for evaluating validity of cognitive data in pwMS. Additional research aiming to elucidate base rates of, mechanisms begetting, and methods for assessing noncredible performance in pwMS is imperative.

Identifiants

pubmed: 34514920
doi: 10.1080/23279095.2021.1971229
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

458-467

Auteurs

Victoria Sanborn (V)

Psychological Sciences, Kent State University, Kent, OH, USA.

John Lace (J)

Cleveland Clinic, Neurological Institute, Section of Neuropsychology, Cleveland, OH, USA.

John Gunstad (J)

Psychological Sciences, Kent State University, Kent, OH, USA.
Brain Health Research Institute, Kent State University, Kent, OH, USA.

Rachel Galioto (R)

Cleveland Clinic, Neurological Institute, Section of Neuropsychology, Cleveland, OH, USA.
Cleveland Clinic, Mellen Center for Multiple Sclerosis, Cleveland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH